The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| YI | -45.45% | -93.53% | -42.16% | -97% |
| S&P | +14.5% | +93.32% | +14.09% | +132% |
111, Inc. engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. It operates through the B2C and B2B segments. The B2C segment engages in the sale of pharmaceutical and other health and wellness products directly to consumers through 1 Drugstore and its offline pharmacies. The B2B segment includes the sale of pharmaceutical products to pharmacy customers through 1 Drug Mall. The company was founded by Gang Yu and Jun Ling Liu in May 2013 and is headquartered in Shanghai, China.
A diamond in the rough is a pretty rare find, especially among Chinese stocks.
Looking to invest in America's top rival? Here are your best bets.
| Q2 2025 | YOY Change | |
|---|---|---|
| Revenue | $443.21M | -6.3% |
| Gross Profit | $25.63M | -10.6% |
| Gross Margin | 5.78% | -0.3% |
| Market Cap | $36.02M | -31.7% |
| Market Cap / Employee | $0.03M | 0.0% |
| Employees | 1.2K | -18.6% |
| Net Income | -$2.76M | -49.5% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q2 2025 | YOY Change | |
|---|---|---|
| Net Cash | $71.61M | 0.9% |
| Accounts Receivable | $47.88M | -28.1% |
| Inventory | 178.4 | -5.2% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $5.99M | -22.5% |
| Short Term Debt | $23.72M | -9.0% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -2.82% | 8.6% |
| Return On Invested Capital | 1741.82% | 14.3% |
| Current | YOY Change | |
|---|---|---|
| Operating Free Cash Flow | -$8.40M | -165.3% |
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | -0.72 | -0.61 | -0.77 | -0.40 | -64.25% |
| Price to Sales | 0.03 | 0.03 | 0.04 | 0.03 | -29.62% |
| Price to Tangible Book Value | -4.42 | -3.44 | -0.45 | -0.40 | -93.82% |
| Total Debt | $33.14M | $39.76M | $26.92M | $29.72M | -12.07% |
YI earnings call for the period ending September 30, 2021.
YI earnings call for the period ending June 30, 2021.
YI earnings call for the period ending March 31, 2021.
YI earnings call for the period ending December 31, 2020.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
